Cargando…

Linagliptin Inhibits Lipopolysaccharide-Induced Inflammation Concentration-Dependently And -Independently

PURPOSE: Dipeptidyl peptidase-4 inhibitors, including linagliptin, prevent inflammation. However, the in vitro effects of linagliptin are unclear. Moreover, although linagliptin inhibits lipopolysaccharide (LPS)-induced inflammation, the anti-inflammatory effects of linagliptin in this context are n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sato, Naoki, Nakamura, Yuya, Yamadera, Shiho, Inagaki, Masahiro, Kenmotsu, Sachiyo, Saito, Hiroshi, Oguchi, Tatsunori, Tsuji, Mayumi, Chokki, Hirokazu, Ohsawa, Isao, Gotoh, Hiromichi, Iwai, Shinichi, Kiuchi, Yuji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6814358/ https://www.ncbi.nlm.nih.gov/pubmed/31695471 http://dx.doi.org/10.2147/JIR.S221761

Ejemplares similares

Linagliptin inhibits lipopolysaccharide-induced inflammation in human U937 monocytes
por: Yamadera, Shiho, et al.
Publicado: (2018)

Linagliptin Inhibits Interleukin-6 Production Through Toll-Like Receptor 4 Complex and Lipopolysaccharide-Binding Protein Independent Pathway in vitro Model
por: Saito, Hiroshi, et al.
Publicado: (2021)

Soy isoflavones inducing overt hypothyroidism in a patient with chronic lymphocytic thyroiditis: a case report
por: Nakamura, Yuya, et al.
Publicado: (2017)

Linagliptin Has Wide-Ranging Anti-Inflammatory Points of Action in Human Umbilical Vein Endothelial Cells
por: Nakamura, Yuya, et al.
Publicado: (2016)

The Impact of Human Parvovirus B19 Infection on Heart Failure and Anemia with Reference to Iron Metabolism Markers in an Adult Woman
por: Nakamura, Yuya, et al.
Publicado: (2017)

Cilostazol Suppresses Aβ-induced Neurotoxicity in SH-SY5Y Cells through Inhibition of Oxidative Stress and MAPK Signaling Pathway
por: Oguchi, Tatsunori, et al.
Publicado: (2017)

Gastrorenal shunt: a cause of hyperammonemia
por: Nakamura, Yuya, et al.
Publicado: (2017)

Neuroprotective Potential of Raloxifene via G-Protein-Coupled Estrogen Receptors in Aβ-Oligomer-Induced Neuronal Injury
por: Nohara, Tetsuhito, et al.
Publicado: (2023)

Combined Treatment with Curcumin and Ferulic Acid Suppressed the Aβ-Induced Neurotoxicity More than Curcumin and Ferulic Acid Alone
por: Ohashi, Hideaki, et al.
Publicado: (2022)

The Curcumin Derivative GT863 Protects Cell Membranes in Cytotoxicity by Aβ Oligomers
por: Momma, Yutaro, et al.
Publicado: (2023)

Linagliptin improves endothelial function in patients with type 2 diabetes: A randomized study of linagliptin effectiveness on endothelial function
por: Shigiyama, Fumika, et al.
Publicado: (2016)

Serum BDNF as a Potential Biomarker of Alzheimer's Disease: Verification Through Assessment of Serum, Cerebrospinal Fluid, and Medial Temporal Lobe Atrophy
por: Mori, Yukiko, et al.
Publicado: (2021)

The clinical application of linagliptin in Asians
por: Cao, Chu-qing, et al.
Publicado: (2015)

Linagliptin: from bench to bedside
por: Doupis, John
Publicado: (2014)

Pharmacokinetic and pharmacodynamic evaluation of linagliptin for the treatment of type 2 diabetes mellitus, with consideration of Asian patient populations
por: Ceriello, Antonio, et al.
Publicado: (2016)

Cost-Effectiveness Analysis of Linagliptin in Japan Based on Results from the Asian Subpopulation in the CARMELINA(®) Trial
por: Watada, Hirotaka, et al.
Publicado: (2020)

Linagliptin ameliorated cardiac fibrosis and restored cardiomyocyte structure in diabetic mice associated with the suppression of necroptosis
por: Adhikari, Juthi, et al.
Publicado: (2023)

Incorrect description of mode of excretion of linagliptin
por: Woerle, Hans-Juergen, et al.
Publicado: (2010)

Acute Kidney Injury Associated with Linagliptin
por: Nandikanti, Deepak K., et al.
Publicado: (2016)

Linagliptin-Associated Alopecia and Bullous Pemphigoid
por: Someili, Ali, et al.
Publicado: (2019)

Analytical Enantio-Separation of Linagliptin in Linagliptin and Metformin HCl Dosage Forms by Applying Two-Level Factorial Design
por: Jadhav, Sushant B., et al.
Publicado: (2016)

Clinical utility and tolerability of linagliptin in diabetic patients
por: Maxwell, Lauralee Gordon, et al.
Publicado: (2013)

Repositioning of Hypoglycemic Drug Linagliptin for Cancer Treatment
por: Li, Yong, et al.
Publicado: (2020)

Atypical Bullous Pemphigoid After Linagliptin Intake
por: Dbouk, Samer, et al.
Publicado: (2021)

Clinical Features of Hereditary and Mast Cell-mediated Angioedema Focusing on the Differential Diagnosis in Japanese Patients
por: Ohsawa, Isao, et al.
Publicado: (2017)

Linagliptin use in older individuals with type 2 diabetes
por: Pratley, Richard E
Publicado: (2014)

Linagliptin Ameliorates Methylglyoxal-Induced Peritoneal Fibrosis in Mice
por: Nagai, Takuo, et al.
Publicado: (2016)

Post-marketing Study of Linagliptin: A Pilot Study
por: Gomes, Gabrielle Kéfrem Alves, et al.
Publicado: (2019)

Empagliflozin/linagliptin: Euglycaemic diabetic ketoacidosis: case report
Publicado: (2021)

Spectrophotometric Methods for the Determination of Linagliptin in Binary Mixture with Metformin Hydrochloride and Simultaneous Determination of Linagliptin and Metformin Hydrochloride using High Performance Liquid Chromatography
por: El-Bagary, Ramzia I., et al.
Publicado: (2013)

Gut Microbiome and Microbiome-Derived Metabolites in Patients with End-Stage Kidney Disease
por: Koshida, Takeo, et al.
Publicado: (2023)

Linagliptin: A thorough Characterization beyond Its Clinical Efficacy
por: Sortino, Maria Angela, et al.
Publicado: (2013)

Linagliptin: farmacology, efficacy and safety in type 2 diabetes treatment
por: Guedes, Erika Paniago, et al.
Publicado: (2013)

Combination of Linagliptin and Metformin for the Treatment of Patients with Type 2 Diabetes
por: Haak, Thomas
Publicado: (2015)

Linagliptin as add-on therapy to insulin for patients with type 2 diabetes
por: von Websky, Karoline, et al.
Publicado: (2013)

Synthesis and Characterization of Process-Related Impurities of Antidiabetic Drug Linagliptin
por: Huang, Yiwen, et al.
Publicado: (2016)

Clinical efficacy of linagliptin combined with irbesartan in patients with diabetic nephropathy
por: Liu, Jie, et al.
Publicado: (2022)

Linagliptin/metformin/pembrolizumab interaction: Various toxicities: case report
Publicado: (2022)

Mild Pancreatitis Induced by Linagliptin Revealed by a Medication Review
por: Gidda, Harish, et al.
Publicado: (2023)

Manipulating Living Cells to Construct Stable 3D Cellular Assembly Without Artificial Scaffold
por: Yamazaki, Takehiro, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_v0ml87mm85pdviakr4te2uva4p